A. Grünewaldt

[State of the art in diagnosis and therapy of community aquired pneumonia].

G. Rohde, C. Bellinghausen, A. Grünewaldt, 2020, MMW Fortschritte der Medizin.

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Matthew A. Wiles, Manisha, Christopher M. Horvat, 2021, Intensive Care Medicine.

[Epitheloid cell granulomas in bronchial invasive mucinous adenocarcinoma].

T. Wagner, A. Grünewaldt, 2015, Pneumologie.

Comorbidity defines asthmatic patients' risk of COVID-19 hospitalization: A global perspective

K. Nadeau, G. Rohde, C. Skevaki, 2022, Journal of Allergy and Clinical Immunology.

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

Matthew A. Wiles, Nerissa C. Brown, Christopher M. Horvat, 2022, JAMA.

Hypercapnic Failure in Acute Exacerbated COPD Patients: Severe Airflow Limitation as an Early Warning Signal

G. Rohde, N. Fritsch, A. Grünewaldt, 2022, Journal of Clinical Medicine.

Pulmonary impairment independently determines mortality in critically ill patients with acute‐on‐chronic liver failure

J. Trebicka, S. Zeuzem, G. Rohde, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry

A. Prasse, W. Gesierich, M. Kreuter, 2023, BMC Pulmonary Medicine.